Malignant progression in multiple enchondromatosis (Ollier's disease):: An autopsy-based molecular genetic study

被引:31
作者
Bovée, JVMG
van Roggen, JFG
Cleton-Jansen, AM
Taminiau, AHM
van der Woude, HJ
Hogendoorn, PCW
机构
[1] Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Orthoped Surg, NL-2300 RC Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Radiol, NL-2300 RC Leiden, Netherlands
关键词
bone neoplasm; Ollier's disease; enchondroma; chondrosarcoma; cytogenetics; molecular biology;
D O I
10.1053/hupa.2000.19308
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Multiple enchondromatosis (Ollier's disease) is a nonhereditary disease characterized by multiple central (medullary) cartilaginous bone tumors of unknown pathogenesis. It usually involves the extremities with a unilateral predominance, and sarcomatous transformation may occur. We report an autopsy-based genetic study of a 34-year-old man presenting in early adolescence with multiple enchondromas of the extremities, predominantly left-sided, compatible with Oilier's disease. Twelve years after presentation, malignant transformation to a high grade chondrosarcoma occurred in a tibial enchondroma. The patient died after widespread metastatic disease. Loss of heterozygosity (LOH), in the tibial chondrosarcoma and its metastases, was identified exclusively on chromosome bands 13q14 and 9p21, while being absent in the femoral enchondroma analyzed. Similarly, p53 overexpression was identified immunohistochemically in the tibial chondrosarcoma and its metastases, while being absent in the femoral enchondroma; LOH at 17p13 however, was not demonstrable. It is hypothesized that inactivation of putative tumor suppressor genes at 9p21 and 13q14, and overexpression of p53, identified in the chondrosarcoma and its metastases, but absent in enchondroma, may be related to sarcomatous transformation in Oilier's disease. HUM PATHOL 31:1299-1303. Copyright (C) 2000 by WB. Saunders Company.
引用
收藏
页码:1299 / 1303
页数:5
相关论文
共 20 条
[1]  
Bovée JVMG, 1999, J PATHOL, V189, P454, DOI 10.1002/(SICI)1096-9896(199912)189:4<454::AID-PATH467>3.0.CO
[2]  
2-N
[3]  
Bovée JVMG, 1999, GENE CHROMOSOME CANC, V26, P237
[4]   EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas [J].
Bovée, JVMG ;
Cleton-Jansen, AM ;
Wuyts, W ;
Caethoven, G ;
Taminiau, AHM ;
Bakker, E ;
Van Hul, W ;
Cornelisse, CJ ;
Hogendoorn, PCW .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (03) :689-698
[5]   BIOLOGIC AND CLINICAL-SIGNIFICANCE OF CYTOGENETIC AND MOLECULAR CYTOGENETIC ABNORMALITIES IN BENIGN AND MALIGNANT CARTILAGINOUS LESIONS [J].
BRIDGE, JA ;
BHATIA, PS ;
ANDERSON, JR ;
NEFF, JR .
CANCER GENETICS AND CYTOGENETICS, 1993, 69 (02) :79-90
[6]  
CANNON SR, 1985, CANCER, V55, P836, DOI 10.1002/1097-0142(19850215)55:4<836::AID-CNCR2820550421>3.0.CO
[7]  
2-F
[8]   P53 EXPRESSION AND DNA-PLOIDY OF CARTILAGE LESIONS [J].
COUGHLAN, B ;
FELIZ, A ;
ISHIDA, T ;
CZERNIAK, B ;
DORFMAN, HD .
HUMAN PATHOLOGY, 1995, 26 (06) :620-624
[9]  
Dyschondorplasie Ollier M, 1900, LYON MED, V93, P23
[10]   COMPLEX CYTOGENETIC ABERRATIONS IN A WELL-DIFFERENTIATED CHONDROSARCOMA [J].
FLETCHER, JA ;
LIPINSKI, KK ;
WEIDNER, N ;
MORTON, CC .
CANCER GENETICS AND CYTOGENETICS, 1989, 41 (01) :115-121